Allergan denied dismissal of patent challenges for dry eye medication Restasis By: MarketWatch February 26, 2018 at 10:16 AM EST Allergan likely expected to have the patent challenges dismissed under a deal with a New York State American Indian tribe. Read More >> Related Stocks: Allergan Plc Mylan Teva Pharmaceutical Industries ADR